PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs

The U.S. Food and Drug Administration, in partnership with international regulatory and law enforcement agencies, acted this week to target 465 websites that illegal...
Continue Reading →
News

Sanofi receives positive CHMP opinion for dengue vaccine

Paris, France - October 19, 2018 - The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the ...
Continue Reading →
News

Global pharma set for strong year with record 164 countries and 44,500[1] attendees at CPhI Worldwide

CPhI Worldwide pharma survey shows improving outlook for pharma economies globally, with China and India showing the fastest improvement. Amsterdam...
Continue Reading →
News

PCI Pharma Services Completes Acquisition of Sherpa Clinical Packaging

PCI continues expansion of its global clinical services network to California. Philadelphia, USA – October 2, 2018 Leading global biopharmaceutical outsourci...
Continue Reading →
News

PCI Clinical Services Announces New Facility Dedicated to Clinical Trial Returns

Continued investment at Bridgend site enables capacity expansion for segregated space in support of the Return of investigational drug products used in C...
Continue Reading →
News

AstraZeneca to continue UK investment freeze due to Brexit uncertainty

Anglo-Swedish biopharma company AstraZeneca’s non-executive chairman Leif Johansson has unveiled to French newspaper La Monde that the company will continue its free...
Continue Reading →
News

Could treating psoriasis in the future be as easy as going online?

For approximately 8 million Americans, visiting a doctor regularly is the key to managing their psoriasis, a chronic inflammatory skin condition characterized by itc...
Continue Reading →
News

CPhI Annual report forecasts CMOs to benefit from double digit approvals for ADCs in the next 3-years.

Summary of trends forecast: the next 1-3 years Novel payloads that target tumour-initiating cells on third generation ADCs could come to market in the next coupl...
Continue Reading →
News

Rheumatoid arthritis: 80% of sufferers can now live a “normal” life

MedUni Vienna researchers invited to review status of the disease in leading journal “JAMA” – World Arthritis Day on 12 October. MedUni Vienna researchers Dan...
Continue Reading →
News

Chemistry’s agile innovators need Brexit safeguards to protect £50bn1 sector

--- Royal Society of Chemistry says SMEs to be disproportionately hit by red tape --- --- 96% of pharma and chemicals companies in UK are SMEs --- --- Access t...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026